"升清降浊"法针刺治疗脓毒症胃肠功能障碍:随机对照试验OA
Shengqing Jiangzhuo acupuncture method for sepsis-associated gastrointestinal dysfunction:a randomized controlled trial
目的:观察"升清降浊"法针刺治疗脓毒症胃肠功能障碍的疗效及安全性,初步探索其作用机制.方法:将96例脓毒症胃肠功能障碍患者随机分为观察组(48例,脱落 1例)和对照组(48例,脱落 5例).观察组在西医常规治疗基础上联合"升清降浊"法针刺治疗,穴取双侧足三里、内关、太冲等,每日1 次,共治疗7 d.对照组在西医常规治疗基础上联合假针刺治疗,取对应非经非穴,每日 1 次,共治疗 7 d.观察两组治疗前及治疗1、3、7 d后急性胃肠损伤超声评分(AGIUS);记录两组肠内营养启动后第1、3、7 天的胃残余量(GRV)和喂养不耐受发生率,肠内营养启动后第1、3天的每日摄取热量,以及达到目标热量所需时间;检测两组治疗前、治疗后外周血炎症指标[白细胞介素(IL)-10、IL-6、肿瘤坏死因子-α(TNF-α)、IL-17A、全身免疫炎症指数(SII)、白细胞计数(WBC)、降钙素原(PCT)]水平,以及序贯器官衰竭评估(SOFA)评分;记录 28 天死亡率及不良反应发生情况.结果:治疗1 d后,观察组AGIUS较治疗前降低(P<0.001);治疗 3、7 d后,两组AGIUS均低于治疗前及治疗1 d后(P<0.001);治疗7 d后,观察组AGIUS低于治疗3 d后(P<0.001);治疗 1、3、7 d后,观察组AGIUS均低于对照组(P<0.001).肠内营养启动后第 3、7 天,两组GRV均低于第 1 天(P<0.001),且第7天低于第 3天(P<0.001);观察组以上各时点GRV均低于对照组(P<0.001).肠内营养启动后第1、3天,观察组喂养不耐受发生率低于对照组(P<0.001,P<0.01),每日摄取热量均高于对照组(P<0.05,P<0.01).观察组达到目标热量所需时间短于对照组(P<0.05).治疗后,两组SOFA评分较治疗前降低(P<0.001),且观察组低于对照组(P<0.001).两组28天死亡率比较,差异无统计学意义(P>0.05).治疗后,观察组IL-6、TNF-α、IL-17A、SII、WBC、PCT 水平均较治疗前降低(P<0.05),IL-10 水平较治疗前升高(P<0.05);对照组 IL-6、WBC水平均较治疗前降低(P<0.05),IL-10 水平较治疗前升高(P<0.05);治疗后除IL-10外,观察组其他炎症指标水平均低于对照组(P<0.01,P<0.05).两组均未出现与针刺治疗及操作相关的不良反应.结论:"升清降浊"法针刺可以改善脓毒症胃肠功能障碍患者胃肠功能,降低早期喂养不耐受风险,其作用机制可能与减轻炎症反应有关.
Objective To observe the efficacy and safety of Shengqing Jiangzhuo(raising the clear and lowering the turbid)acupuncture method for sepsis-associated gastrointestinal dysfunction,and to preliminarily explore its mechanism.Methods Ninety-six patients with sepsis-associated gastrointestinal dysfunction were randomly divided into an observation group(48 cases,1 case dropped out)and a control group(48 cases,5 cases dropped out).The observation group was treated with Shengqing Jiangzhuo acupuncture method on the basis of conventional western medical treatment,with acupoints including bilateral Zusanli(ST36),Neiguan(PC6),and Taichong(LR3),once daily for 7 days.The control group was treated with sham acupuncture on the basis of conventional western medical treatment,with corresponding non-acupoints,once daily for 7 days.Acute gastrointestinal injury ultrasonography score(AGIUS)was assessed before treatment and after 1,3,and 7 days of treatment.Gastric residual volume(GRV)and incidence of feeding intolerance on days 1,3,and 7 after initiation of enteral nutrition,daily caloric intake on days 1 and 3,and time required to reach target caloric intake were recorded.Peripheral blood inflammatory indexes[interleukin(IL)-10,IL-6,tumor necrosis factor-α(TNF-α),IL-17A,systemic immune-inflammation index(SII),white blood cell count(WBC),and procalcitonin(PCT)]and sequential organ failure assessment(SOFA)score were measured before and after treatment.The 28-day mortality and adverse events were recorded.Results After 1 day of treatment,AGIUS in the observation group was lower than that before treatment(P<0.001).After 3 and 7 days of treatment,AGIUS in both groups were lower than those before treatment and after 1 day of treatment(P<0.001).After 7 days of treatment,AGIUS in the observation group was lower than that after 3 days of treatment(P<0.001).After 1,3,and 7 days of treatment,AGIUS in the observation group were lower than those in the control group(P<0.001).On days 3 and 7 after initiation of enteral nutrition,GRV in both groups was lower than that on day 1(P<0.001),and GRV on day 7 was lower than that on day 3(P<0.001);GRV in the observation group at all time points was lower than that in the control group(P<0.001).On days 1 and 3 after initiation of enteral nutrition,the incidence of feeding intolerance in the observation group was lower than that in the control group(P<0.001,P<0.01),and daily caloric intake was higher than that in the control group(P<0.05,P<0.01).The time required to reach target caloric intake in the observation group was shorter than that in the control group(P<0.05).After treatment,SOFA scores in both groups were lower than those before treatment(P<0.001),and SOFA score in the observation group was lower than that in the control group(P<0.001).There was no statistically significant difference in 28-day mortality between the two groups(P>0.05).After treatment,the levels of IL-6,TNF-α,IL-17A,SII,WBC,and PCT in the observation group were lower than those before treatment(P<0.05),and IL-10 level was higher than that before treatment(P<0.05);in the control group,IL-6 and WBC levels were lower than those before treatment(P<0.05),and IL-10 level was higher than that before treatment(P<0.05).After treatment,except for IL-10,other inflammatory indexes in the observation group were lower than those in the control group(P<0.01,P<0.05).No adverse events related to acupuncture treatment or operation occurred in either group.Conclusion Shengqing Jiangzhuo acupuncture method can improve gastrointestinal function in patients with sepsis-associated gastrointestinal dysfunction,reduce the risk of early feeding intolerance.Its mechanism may be related to alleviating inflammatory response.
许欣宜;肖璐;高颖;缪长宏;山子淇;张译方;王元翀;杨晓琨;石存忠
天津中医药大学第一附属医院,急症部,天津 300381||中医国家临床医学研究中心,天津 300381天津中医药大学第一附属医院,急症部,天津 300381||中医国家临床医学研究中心,天津 300381天津中医药大学第一附属医院,急症部,天津 300381||中医国家临床医学研究中心,天津 300381天津中医药大学第一附属医院,急症部,天津 300381||中医国家临床医学研究中心,天津 300381天津中医药大学第一附属医院,急症部,天津 300381||中医国家临床医学研究中心,天津 300381天津中医药大学第一附属医院,急症部,天津 300381||中医国家临床医学研究中心,天津 300381天津中医药大学第一附属医院,急症部,天津 300381||中医国家临床医学研究中心,天津 300381中医国家临床医学研究中心,天津 300381||天津中医药大学第一附属医院,教学处,天津 300381天津中医药大学第一附属医院,急症部,天津 300381||中医国家临床医学研究中心,天津 300381
脓毒症胃肠功能障碍针刺急性胃肠损伤超声评分(AGIUS)随机对照试验
sepsis-associated gastrointestinal dysfunctionacupunctureacute gastrointestinal injury ultrasound score(AGIUS)randomized controlled trial(RCT)
《中国针灸》 2026 (6)
883-891,9
国家自然科学基金资助项目:82405123河北省中医药管理局科研项目:T2025106天津市教委科研计划项目:2021KJ144天津市研究生科研创新项目:2022BKY190天津中医药大学研究生科研创新项目:YJSKC-20222001
评论